Update on the Management of Rheumatoid Arthritis with Special Emphasis on Biologic Agents

Venue: Web-based program

Location: Web-based program, United States

Event Date/Time: Nov 11, 2002 End Date/Time: Nov 01, 2003
Report as Spam


This course is designed to educate primary care physicians, rheumatologists, arthritis health professionals and orthopaedic surgeons on the indications for, side effects from and monitoring needed when employing Biologic Response Modifiers in the treatment of rheumatoid arthritis (RA) and other systemic inflammatory disorders.

At the conclusion of the course the participant will be able to:

1. UNDERSTAND the indications for the use of biologic response modifiers (BRM)
2. APPRECIATE the potential side effects from and optimal monitoring for Biologic response modifiers
3. DEFINE the appropriate outcomes needed to assess the effectiveness of BRM
4. UNDERSTAND how the BRMs are incorporated into the treatment armamentarium for RA and other systemic inflammatory disorders

Weill Medical College of Cornell University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

Weill Medical College of Cornell University designates this educational activity for a maximum of 1 credit hours in Category 1 towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

AAPA accepts AMA Category 1 credit for the PRA from organizations accredited by ACCME.


Additional Information

There is no charge for taking this course or for CME processing at this time. This course is a self-paced streaming lecture with text, video and audio versions. A slide show accompanies each lecture and the slide flips are driven automatically. CME credit is granted with the successful (at least 70% correct responses) completion of the included quiz and by filling out a required evaluation form.